Reanalysis of TransVax immunogenicity

Lancet Infect Dis. 2013 Jan;13(1):18. doi: 10.1016/S1473-3099(12)70296-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibody Formation
  • Clinical Trials, Phase II as Topic
  • Cytomegalovirus / immunology*
  • Cytomegalovirus Infections / immunology*
  • Humans
  • Vaccines, DNA / immunology*
  • Viral Vaccines / immunology*

Substances

  • Vaccines, DNA
  • Viral Vaccines